Published in N Engl J Med on January 01, 1987
The haematology of hyperthyroidism: abnormalities of erythrocytes, leucocytes, thrombocytes and haemostasis. Postgrad Med J (1988) 1.06
Treatment of thyrotoxicosis resistant to carbimazole with corticosteroids. Postgrad Med J (1996) 0.99
Modulation of the IL-2 production defect in vitro in Graves' disease. Clin Exp Immunol (1994) 0.75
In vitro production of interferon-gamma by peripheral blood from patients with Graves' disease, Hashimoto's thyroiditis and rheumatoid arthritis. Clin Exp Immunol (1990) 0.75
Circulating viral and thyroid antibodies in subacute thyroiditis. J Clin Endocrinol Metab (1967) 2.01
Retracted Peripheral thymus-dependent (T) lymphocytes in Graves's disease and Hashimoto's thyroiditis. N Engl J Med (1973) 1.68
Riedel's thyroiditis associated with Hashimoto's thyroiditis, hypoparathyroidism, and retroperitoneal fibrosis. J Endocrinol Invest (1991) 1.51
Immunology of autoimmune thyroid diseases. N Engl J Med (1982) 1.38
Cell-mediated immunity in the exophthalmos of Graves' disease as demonstrated by the migration inhibition factor (MIF) test. J Clin Endocrinol Metab (1973) 1.30
Studies of serum triiodothyronine concentration in maternal and cord blood: transfer of triiodothyronine across the human placenta. J Clin Endocrinol Metab (1969) 1.29
The role of autoimmunity in hypoendocrine and hyperendocrine function: with special emphasis on autoimmune thyroid disease. Ann Intern Med (1977) 1.28
Immunologic aspects of Graves' and Hashimoto's diseases. Metabolism (1980) 1.08
Rosette inhibition test for the demonstration of thymus-dependent lymphocyte sensitization in Grave's disease and Hashimoto's thyroiditis. N Engl J Med (1973) 1.07
The pathogenesis of Graves' disease: an overview. Clin Endocrinol Metab (1978) 1.06
Cell-mediated immunity in Graves' disease and in Hashimoto's thyroiditis as shown by the demonstration of migration inhibition factor (MIF). J Clin Endocrinol Metab (1973) 1.05
Thyrotropin displacement activity of serum immunoglobulins from patients with Graves' disease. J Clin Endocrinol Metab (1978) 1.05
Lack of significant binding of L-triiodothyronine by thyroxine-binding globulin in vivo as demonstrated by acute disappearance of 131-I-labeled triiodothyronine. J Clin Invest (1966) 1.04
Correlation between thyrotropin-displacing activity and human thyroid-stimulating activity by immunoglobulins from patients with Graves' disease and other thyroid disorders. J Clin Endocrinol Metab (1979) 1.00
Subacute (de Quervain's) thyroiditis. Clin Endocrinol Metab (1979) 0.99
The pathogenesis of Graves' disease and Hashimoto's thyroiditis. Clin Endocrinol (Oxf) (1974) 0.98
Thyrocyte HLA-DR expression and interferon-gamma production in autoimmune thyroid disease. J Clin Endocrinol Metab (1986) 0.98
Letter: Proportion of E rosettes normal in Graves's and Hashimoto's disease: a retraction. N Engl J Med (1975) 0.96
Evidence for cell-mediated immunity and specific suppressor T lymphocyte dysfunction in Graves' disease and diabetes mellitus. J Clin Endocrinol Metab (1983) 0.94
The pathology of thyroiditis. Hum Pathol (1978) 0.91
Evidence that antithyroid drugs induce remissions in Graves' disease by modulating thyroid cellular activity. Clin Endocrinol (Oxf) (1986) 0.90
Studies on the immunoregulation of thyroid autoantibody production in vitro. Clin Exp Immunol (1985) 0.88
Increased requirement for thyroid hormone after a jejunoileal bypass operation. Can Med Assoc J (1980) 0.87
Spontaneous secretion of thyroid autoantibodies by cultured peripheral blood lymphocytes from patients with Hashimoto's thyroiditis detected by micro-ELISA techniques. Clin Exp Immunol (1984) 0.87
Human minimal androgen insensitivity with normal dihydrotestosterone-binding capacity in cultured genital skin fibroblasts: evidence for an androgen-selective qualitative abnormality of the receptor. Am J Hum Genet (1984) 0.86
Further studies on the rate of disappearance of labelled thyroxine from the intravascular compartment of man, with reference to the role of thyroxine binding proteins. Acta Endocrinol (Copenh) (1967) 0.86
Action of globulin and lymphocytes from peripheral blood of patients with Graves' disease on isolated bovine thyroid cells. J Clin Endocrinol Metab (1970) 0.86
Seroreactivity to bacterial antigens is not a unique phenomenon in patients with autoimmune thyroid diseases in Canada. Thyroid (1994) 0.86
Etiology, pathogenesis, and clinical aspects of thyroiditis. Pathol Annu (1978) 0.86
The influence of liver damage in man on the distribution and disposal rates of thyroxine and triiodothyronine. J Clin Endocrinol Metab (1972) 0.85
Thyroid antigen stimulates lymphocytes from patients with Graves' disease to produce thyroid-stimulating immunoglobulin (TSI). J Clin Endocrinol Metab (1976) 0.84
Studies of thyroid xenografts from Graves' disease in severe combined immunodeficient mice. J Clin Endocrinol Metab (1993) 0.83
Graves' disease in pregnancy years after hypothyroidism with recurrent passive-transfer neonatal Graves' disease in offspring. Therapeutic considerations. Am J Med (1984) 0.83
Sensitization of T-lymphocytes in Graves' and Hashimoto's diseases. J Clin Endocrinol Metab (1980) 0.82
Lymphocytic hypophysitis. Ann Intern Med (1981) 0.82
Report of a case of pheochromocytoma producing immunoreactive ACTH and beta-endorphin. J Endocrinol Invest (1984) 0.82
Iodide metabolism in Ontario. Acta Endocrinol (Copenh) (1967) 0.82
Studies of the effect of suppressor T lymphocytes on the induction of antithyroid microsomal antibody-secreting cells in autoimmune thyroid disease. J Clin Endocrinol Metab (1988) 0.81
Demonstration of the production of human thyroid-stimulating immunoglobulins (HTSI) by Graves' lymphocytes cultured in vitro with phytohaemagglutinin (PHA). Metabolism (1976) 0.81
Concordant Graves' disease after bone marrow transplantation: implications for pathogenesis. J Clin Endocrinol Metab (1991) 0.81
The effect of blood leucocytes from patients with Hashimoto's disease on human thyroid cells in monolayer culture. Clin Endocrinol (Oxf) (1973) 0.80
The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS). Am J Med (1969) 0.80
Suppressor T lymphocyte dysfunction in Graves' disease: role of the H-2 histamine receptor-bearing suppressor T lymphocytes. J Clin Endocrinol Metab (1981) 0.80
Effect of HLA-DR positive thyrocytes on in vitro thyroid autoantibody production. Clin Invest Med (1988) 0.80
T lymphocyte sensitization and suppressor T lymphocyte defect in patients long after treatment for Graves' disease. Clin Endocrinol (Oxf) (1983) 0.80
Immunopathology of Graves' disease. Fed Proc (1979) 0.79
Is silent thyroiditis an autoimmune disease? Arch Intern Med (1988) 0.79
Hashimoto's thyroiditis manifesting monoclonal lymphocytic infiltration. Clin Exp Immunol (1990) 0.79
Lack of effect of methimazole on thyrocyte cell-surface antigen expression. Autoimmunity (1989) 0.79
T-lymphocyte sensitization in Graves' and Hashimoto's diseases confirmed by an indirect migration inhibition factor test. J Clin Endocrinol Metab (1981) 0.79
Allosuppressor T lymphocytes abolish migration inhibition factor production in autoimmune thyroid disease: evidence from radiosensitivity experiments. Clin Endocrinol (Oxf) (1981) 0.79
Antibody to gp39, the ligand for CD40 significantly inhibits the humoral response from Graves' thyroid tissues xenografted into severe combined immunodeficient (SCID) mice. Thyroid (1996) 0.79
Separate induction of MHC and thyroid microsomal antigen (McAg) expression on thyroid cell monolayers: enhancement of lectin-induced McAg expression by interferon-gamma. J Clin Endocrinol Metab (1987) 0.78
Comparison of thyroid antigens by the experimental production of precipitating antibodies to human thyroid fractions and the identification of an antibody which competes with long-acting thyroid stimulator (LATS) for thyroid binding. Acta Endocrinol (Copenh) (1977) 0.78
Suppurative thyroiditis: an unusual case caused by Actinomyces naeslundi. Can Med Assoc J (1969) 0.78
Autoimmune thyroiditis, adrenalitis and oophoritis. Am J Med (1973) 0.78
Activation of T lymphocyte subsets by synthetic TSH receptor peptides and recombinant glutamate decarboxylase in autoimmune thyroid disease and insulin-dependent diabetes. J Clin Endocrinol Metab (1995) 0.78
Autoimmune thyroid disease--a perspective. Mol Biol Med (1986) 0.78
Thyroiditis: current views of pathogenesis. Med Clin North Am (1975) 0.78
A case of testicular feminization with XYY karyotype. Clin Endocrinol (Oxf) (1974) 0.78
Accumulation and rlease of thyroid hormones by the normal and diseased human liver. Acta Endocrinol (Copenh) (1969) 0.78
Relationship of age-specific incidence rates to immunological aspects of Hashimoto's thyroiditis. Can Med Assoc J (1973) 0.78
Biological activity of lymphocytotoxic antibodies in Graves' disease and Hashimoto's thyroiditis. J Endocrinol Invest (1984) 0.77
Thyrocyte class I and class II upregulation is a secondary phenomenon and does not contribute to the pathogenesis of autoimmune thyroid disease. Thyroid (1998) 0.77
Induction of thyroid autoantibody production: synergistic effect of B cell mitogen combined with T cell mitogen. J Clin Endocrinol Metab (1987) 0.77
Effects of recombinant human interleukin-2 and tumor necrosis factor-alpha with or without interferon-gamma on human thyroid tissues from patients with Graves' disease and from normal subjects xenografted into nude mice. J Clin Endocrinol Metab (1991) 0.77
Thyroid-stimulating hormone (TSH) binding to extrathyroidal human tissues: TSH binding to extrathyroidal human tissues: TSH and thyroid-stimulating immunoglobulin effects on adenosine 3',5'-monophosphate in testicular and adrenal tissues. J Clin Endocrinol Metab (1979) 0.77
Expression of intercellular adhesion molecule-1 on human thyroid cells from patients with autoimmune thyroid disease: study of thyroid xenografts in nude and severe combined immunodeficient mice and treatment with FK-506. J Clin Endocrinol Metab (1995) 0.77
Studies of HLA-DR expression on cultured human thyrocytes: effect of antithyroid drugs and other agents on interferon-gamma-induced HLA-DR expression. J Clin Endocrinol Metab (1988) 0.77
In vitro induction of anti-thyroid microsomal antibody-secreting cells in peripheral blood mononuclear cells from normal subjects. J Clin Endocrinol Metab (1988) 0.77
Induction of monocyte procoagulant activity with OKT3 antibody. J Immunol (1987) 0.77
The effect of xenotransplantation of human thyroid tissue following radioactive iodine-induced thyroid ablation on thyroid function in the nude mouse. Clin Invest Med (1991) 0.77
Effects of recombinant human interferon gamma on human thyroid tissues from patients with Graves' disease and normal subjects transplanted into nude mice. J Endocrinol Invest (1990) 0.76
Is human leukocyte antigen-DR and intercellular adhesion molecule-1 expression on human thyrocytes constitutive in papillary thyroid cancer? Comparative studies in human thyroid xenografts in severe combined immunodeficient and nude mice. J Clin Endocrinol Metab (1998) 0.76
Thyroid xenografts from patients with Graves' disease in severe combined immunodeficient mice and NIH-beige-nude-xid mice. Clin Invest Med (1997) 0.76
Thyrostatic drugs act through modulation of thyroid cell activity to induce remissions in Graves' disease. Acta Endocrinol Suppl (Copenh) (1987) 0.76
Activation of CD8+ T lymphocytes in insulin-dependent diabetes mellitus. Clin Immunol Immunopathol (1997) 0.76
Differential effects of human interferon alpha and interferon gamma on xenografted human thyroid tissue in severe combined immunodeficient mice and nude mice. Proc Assoc Am Physicians (1997) 0.76
The immunologic basis of Graves's disease. N Engl J Med (1972) 0.76
In vitro effects of cytokines and human thyroglobulin on the induction of antibody-secreting cells in patients with auto-immune thyroid disease. Clin Invest Med (1993) 0.76
The effect of interleukin-2 on suppressor T lymphocytes in autoimmune thyroid disease. Clin Invest Med (1995) 0.76
Cell-mediated immunity in thyroid disease. Br Med J (1973) 0.75
Editorial: Diagnosis of thyroid diseases. Can Med Assoc J (1974) 0.75
Graves' antibody. Can Med Assoc J (1983) 0.75
In vitro production of interferon-gamma by peripheral blood from patients with Graves' disease, Hashimoto's thyroiditis and rheumatoid arthritis. Clin Exp Immunol (1990) 0.75
Study of induction of activation of human peripheral blood mononuclear cells with a non-activating form of anti-CD3 MoAb in autoimmune thyroid disease (AITD). Clin Exp Immunol (1993) 0.75
The role of cytokines in the development of autoimmune thyroid disease. Thyroid (1993) 0.75
Cushing's syndrome in childhood. Can Med Assoc J (1972) 0.75
Immunological aspects of autoimmune thyroiditis. Can Med Assoc J (1974) 0.75
Compensated autoimmune adrenocortical insufficiency. J R Soc Med (1988) 0.75
What is the best test for monitoring levothyroxine therapy? Can Med Assoc J (1981) 0.75
Immunomodulatory effects of antithyroid drugs. Thyroid (1994) 0.75
Effect of removing human Graves' thyroid xenografts after eight weeks in nude mice and rexenografting them into SCID mice. J Clin Endocrinol Metab (1994) 0.75
Homing of 51Cr-labeled human peripheral lymphocytes to Graves' thyroid tissue xenografted into SCID mice. Thyroid (1995) 0.75
Effect of FK-506 on xenografted human Graves' thyroid tissue is severe combined immunodeficient mice. Clin Endocrinol (Oxf) (1994) 0.75
Studies of human thyroid xenografts from Hashimoto's thyroiditis in severe combined immunodeficient (SCID) mice: detection of thyroid stimulation-blocking antibody. Thyroid (1994) 0.75
Studies of human peripheral blood mononuclear cells (PBMC) from patients with subacute thyroiditis in severe combined immunodeficient (SCID) mice: less production of human interferon gamma than that seen for Graves' disease. Horm Metab Res (1994) 0.75
The effect of adding a surfeit of autologous CD8+ T cells to SCID mice after secondary rexenografts of Graves' thyroid tissue. Thyroid (1996) 0.75
Studies of restriction fragment length polymorphism (RFLP) of DR and DQ genes in HLA-DR3 positive patients with Graves' disease or systemic lupus erythematosus. Clin Invest Med (1993) 0.75